Prognostic Significance of Visit‐to‐visit Blood Pressure Variability for Cognitive Outcomes, Vascular Events, and All‐Cause Mortality in a Memory‐Clinic Cohort

Jiangbo Cui, Saima Hilal, Christopher ChenAlzheimer 2024 · DOI

TL;DR

This study reveals that fluctuations in blood pressure (BPV) over time, not just the average BP, are a significant predictor of cognitive decline and mortality in individuals attending memory clinics. This suggests that managing BP variability could be a new target for interventions to preserve cognitive health in older adults.

What Problem Does This Paper Address?

In the realm of aging and cognitive health, blood pressure (BP) is a well-established risk factor. However, most research has focused on the average BP level. This paper tackles a less understood aspect: visit-to-visit blood pressure variability (BPV). This refers to how much an individual's BP fluctuates between different doctor's appointments. The authors question whether these fluctuations, independent of the average BP, hold prognostic value for cognitive decline, vascular events, and overall mortality, particularly within a memory-clinic setting where these outcomes are of primary concern. Understanding this could refine our approach to managing cardiovascular health in aging populations.

Methods

The researchers utilized data from an ongoing longitudinal memory clinic study. They included 590 participants who had at least three annual visits and a baseline MRI scan.

  • Cognitive Decline: Defined by specific annual increases in the Clinical Dementia Rating (CDR) sum of boxes, with different thresholds for individuals with no cognitive impairment (NCI), cognitive impairment no dementia (CIND), and dementia. Incident dementia was identified as a transition from NCI or CIND to dementia.
  • Vascular Events: Defined as the occurrence of cardiovascular disease, transient ischemic attack, or stroke.
  • Neurodegeneration & Cerebrovascular Disease: Assessed via MRI scans, with medial temporal lobe atrophy score >2 indicating neurodegeneration and visual grading used for significant cerebrovascular disease (sCeVD).
  • Statistical Modeling: The core analytical technique was time-dependent joint models. These are sophisticated statistical models that can simultaneously analyze multiple longitudinal outcomes (like cognitive function) and time-to-event outcomes (like mortality or vascular events), while accounting for the fact that one event (e.g., mortality) can prevent the occurrence of another. Crucially, these models adjusted for mean BP, sCeVD, neurodegeneration, and other confounders, and explicitly handled mortality as a competing risk.

Datasets

The study used data from an ongoing longitudinal memory clinic study. No new datasets were introduced, and no benchmarks were specifically created or compared against in this paper.

Key Insights and Ideas

  • BPV as an Independent Risk Factor: The most striking insight is that BPV appears to be an independent predictor of cognitive decline and mortality, even after accounting for average BP, existing cerebrovascular disease, and neurodegeneration. This suggests that the stability of BP is as important, if not more so, than its average level for brain health.
  • Prognostic Value Beyond Mean BP: The findings highlight that focusing solely on achieving a target average BP might miss a crucial aspect of risk management. BPV offers additional prognostic information that could be leveraged for better patient stratification and intervention.
  • Impact on Dementia-Free Individuals: The association between systolic BPV and cognitive decline was particularly significant in participants who were initially dementia-free. This implies that BPV might be an early warning sign or a contributing factor to the onset of cognitive impairment.
  • Modifiable Risk Factor Potential: The conclusion suggests that BPV could be a modifiable risk factor. This opens up exciting avenues for therapeutic interventions aimed at stabilizing blood pressure, potentially slowing cognitive decline and reducing mortality risk.

Key Results

Over a mean follow-up of 3.28 years:

  • A per 1-SD increase in systolic BPV (SBPV) was associated with a higher risk of cognitive decline (Hazard Ratio [HR]: 1.03, 95% CI: 1.00-1.05, p=0.021).
  • A per 1-SD increase in SBPV was associated with a higher risk of incident dementia (HR: 1.09, 95% CI: 1.02-1.15, p=0.002).
  • Increased SBPV was also associated with a higher risk of all-cause mortality (HR: 1.08, 95% CI: 1.03-1.13, p=0.006).
  • SBPV was not significantly associated with vascular events.
  • Similar findings were observed for diastolic BPV.
  • The associations of SBPV with cognitive decline remained significant even after adjusting for sCeVD and neurodegeneration.

Limitations and Future Work

  • Study Population: The study was conducted in a memory-clinic cohort, which may not be representative of the general older adult population. The findings might be more pronounced or different in individuals without existing cognitive concerns.
  • BP Measurement: The paper doesn't detail the specific protocol for BP measurements (e.g., time of day, patient posture), which could influence variability.
  • Causality: While the study identifies associations, it cannot definitively prove causation. Further research is needed to establish a causal link between BPV and the observed outcomes.
  • Intervention Studies: The authors suggest that future work should focus on intervention studies to determine if strategies to reduce BPV can indeed mitigate cognitive decline and mortality. Exploring the mechanisms by which BPV impacts the brain is also a key future direction.

Summary updated

Abstract

Abstract Background The clinical relevance of visit‐to‐visit blood pressure variability (BPV) remains unclear in the memory‐clinic setting. We aimed to investigate the prognostic significance of BPV for cognitive outcomes, vascular events, and all‐cause mortality in a memory‐clinic population. Method The study included 590 participants from an ongoing longitudinal memory clinic study who had ≥ 3 annual visits and a baseline MRI scan. Cognitive decline was defined as an annual increase of 0.5, 1, and 2 in the Clinical Dementia Rating sum of boxes for participants with No Cognitive impairment (NCI), Cognitive Impairment No Dementia (CIND), and dementia, respectively. Incident dementia was identified as transition from NCI or CIND to dementia. Incident vascular event was characterized as occurrence of cardiovascular disease, transient ischemic attack, or stroke. Significant cerebrovascular disease (sCeVD) was defined by MRI visual grading, and medial temporal lobe atrophy score ≥2 indicated neurodegeneration. Time‐dependent joint models were used, adjusting for mean BP, sCeVD, neurodegeneration, and other confounding factors, and accounting for mortality as a competing risk when necessary. Result Over a mean (SD) follow‐up of 3.28 (1.12) years after the second BP measurement, 294 cases of cognitive decline, 75 cases of incident dementia, 34 vascular events, and 59 cases of all‐cause mortality were recorded. Per 1‐SD increase in systolic BPV (SBPV) is associated with a higher risk of cognitive decline (HR: 1.03, 95% CI: 1.00 to 1.05, p = 0.021) and a higher risk of dementia (HR: 1.09, 95% CI: 1.02 to 1.15, p = 0.002). Subgroup analyses showed that association of SBPV with cognitive decline was significant in dementia‐free participants but non‐significant in those with dementia. These associations remained significant after adjusting for sCeVD and neurodegeneration. Increased SBPV was also associated with all‐cause mortality (HR: 1.08, 95% CI: 1.03 to 1.13, p = 0.006), but not with vascular events. Similar findings were observed with diastolic BPV. Conclusion Increased visit‐to‐visit BPV was associated with cognitive decline independent of mean BP, sCeVD and neurodegeneration among non‐demented older adults. Our findings suggest BPV may be a modifiable risk factor for adverse events and provide prognostic insights beyond mean BP in memory clinics.
BibTeX
@inproceedings{cui2024prognostic,
  author = {Jiangbo Cui and Saima Hilal and Christopher Chen},
  title = {{Prognostic Significance of Visit‐to‐visit Blood Pressure Variability for Cognitive Outcomes, Vascular Events, and All‐Cause Mortality in a Memory‐Clinic Cohort}},
  booktitle = {Alzheimer},
  year = {2024},
  doi = {10.1002/alz.095086},
}
Figure